Dymon Asia Capital (Singapore) Pte. Ltd. Astrazeneca PLC Transaction History
Dymon Asia Capital (Singapore) Pte. Ltd.
- $416 Million
- Q4 2024
A detailed history of Dymon Asia Capital (Singapore) Pte. Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Dymon Asia Capital (Singapore) Pte. Ltd. holds 16,000 shares of AZN stock, worth $1.19 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
16,000Holding current value
$1.19 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...